Related Experiment Videos
Pursuit eye movement dysfunction in HIV-1 seropositive individuals
J A Sweeney1, B J Brew, J G Keilp
1University of Pittsburgh, PA.
Journal of Psychiatry & Neuroscience : JPN
|December 1, 1991
Summary
Early HIV-1 infection can cause subtle eye movement problems, even before AIDS Dementia Complex symptoms appear. These smooth pursuit disturbances indicate potential central nervous system (CNS) involvement and may help monitor disease progression.
Area of Science:
- Neuroscience
- Ophthalmology
- Infectious Diseases
Background:
- Human Immunodeficiency Virus type 1 (HIV-1) infection can affect the central nervous system (CNS).
- AIDS Dementia Complex (ADC) is a known neurological complication of advanced HIV-1.
- Early CNS changes in HIV-1 may not be clinically apparent.
Purpose of the Study:
- To investigate smooth pursuit eye movements in HIV-1 seropositive individuals without marked ADC symptoms.
- To determine if oculomotor disturbances correlate with disease markers and clinical staging.
- To assess the utility of eye movement studies for early CNS involvement detection in HIV-1.
Main Methods:
- Smooth pursuit eye movements were assessed in 30 ambulatory, drug-free HIV-1 seropositive patients.
- Patients had no marked clinical signs of ADC at the time of the study.
- Correlations were examined between eye movement data, immunosuppression levels, neuropsychological test results, and ADC clinical stage.
Main Results:
- HIV-1 seropositive patients exhibited disturbances in smooth pursuit eye movements.
- These oculomotor impairments correlated with the degree of immunosuppression.
- Eye movement abnormalities were also linked to deficits in fine motor control/speed and ADC clinical staging.
Conclusions:
- Oculomotor disturbances are detectable in HIV-1 seropositive individuals prior to the development of significant ADC.
- Quantitative eye movement analysis may serve as a sensitive neurobehavioral marker for early CNS involvement in HIV-1.
- This methodology could be valuable for monitoring the progression of neurological complications in HIV-1 infection.